Quality of life (QoL) in ovarian cancer patients following hyperthermic intraperitoneal chemotherapy (HIPEC) versus intraperitoneal (IP) chemotherapy.

Saved in:
Bibliographic Details
Title: Quality of life (QoL) in ovarian cancer patients following hyperthermic intraperitoneal chemotherapy (HIPEC) versus intraperitoneal (IP) chemotherapy.
Authors: Dellinger, T.1 (AUTHOR), Lee, S.J.1 (AUTHOR), Sun, V.1 (AUTHOR), Ruel, N.H.1 (AUTHOR), Liu, X.1 (AUTHOR), Lin, W.C.M.1 (AUTHOR), Kebria, M.1 (AUTHOR), Han, E.S.1 (AUTHOR)
Source: Gynecologic Oncology. Jul2019:Supplement 1, Vol. 154, p214-214. 1p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2019.04.496